← Back to Search

Peer Mentors for Eating Disorders

N/A
Recruiting
Led By Aaron K Keshen
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3-6 months, 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will investigate how effective and acceptable peer mentors are in helping youth with an eating disorder transition from youth-oriented to adult-oriented treatment. Participants, their carers and peer mentors will be interviewed.

Who is the study for?
This trial is for young people aged 16-24 in Nova Scotia, New Brunswick, or Prince Edward Island with an eating disorder diagnosis. They should be transitioning to adult treatment and not at high suicide risk. Participants must understand English well and give consent.
What is being tested?
The study tests if peer mentors can help youths transition to adult eating disorder treatments effectively. It involves a 3-6 month mentorship, questionnaires before, after, and a year later, plus interviews about the care transition experience.
What are the potential side effects?
There are no medical side effects as this is not a drug trial; however, participants may experience emotional or psychological impacts from discussing their experiences with eating disorders during interviews.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3-6 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3-6 months, 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Autonomous Motivation
Secondary study objectives
Completed Transitions
Patient acceptability
Other study objectives
Change in clinical impairment
Eating Disorders
Change in feelings of competence about participating in eating disorder treatment

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: TAY receiving peer mentor interventionExperimental Treatment1 Intervention
Transition age youth with EDs (n=35) will receive a peer mentor delivered transition intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peer mentor intervention
2003
Completed Phase 3
~400

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityLead Sponsor
288 Previous Clinical Trials
94,513 Total Patients Enrolled
Aaron K KeshenPrincipal InvestigatorNova Scotia Health Authority

Media Library

Peer mentor intervention Clinical Trial Eligibility Overview. Trial Name: NCT05543044 — N/A
Anorexia nervosa Research Study Groups: TAY receiving peer mentor intervention
Anorexia nervosa Clinical Trial 2023: Peer mentor intervention Highlights & Side Effects. Trial Name: NCT05543044 — N/A
Peer mentor intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05543044 — N/A
~21 spots leftby Mar 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top